Growth Metrics

Rigel Pharmaceuticals (RIGL) Cash & Equivalents Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -51.77%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 24.73%
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -28.55%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 13.33%
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -16.07%
7 Evaxion A 62.56 Bn 62.54 Bn - 21.66%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -8.88%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 36.53%
10 Rigel Pharmaceuticals 551.62 Mn 404.94 Mn 54.21 Mn -15.38%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -15.38%
Dec 31, 2025 18.38%
Sep 30, 2025 17.57%
Jun 30, 2025 25.22%
Mar 31, 2025 22.82%
Dec 31, 2024 44.29%
Sep 30, 2024 19.35%
Jun 30, 2024 -24.81%
Mar 31, 2024 8.46%
Dec 31, 2023 2.58%
Sep 30, 2023 7.49%
Jun 30, 2023 10.20%
Mar 31, 2023 -3.78%
Dec 31, 2022 2.79%
Sep 30, 2022 -8.58%
Jun 30, 2022 -14.96%
Mar 31, 2022 -30.87%
Dec 31, 2021 -37.21%
Sep 30, 2021 -20.92%
Jun 30, 2021 9.23%
Mar 31, 2021 -20.65%
Dec 31, 2020 -7.43%
Sep 30, 2020 12.21%
Jun 30, 2020 3.82%
Mar 31, 2020 4.05%
Dec 31, 2019 8.50%
Sep 30, 2019 14.64%
Jun 30, 2019 21.03%
Mar 31, 2019 73.63%
Dec 31, 2018 20.65%
Sep 30, 2018 16.81%
Jun 30, 2018 55.55%
Mar 31, 2018 -2.07%
Dec 31, 2017 36.06%
Sep 30, 2017 26.40%
Jun 30, 2017 10.92%
Mar 31, 2017 39.12%
Dec 31, 2016 -5.44%
Sep 30, 2016 17.42%
Jun 30, 2016 4.49%
Mar 31, 2016 -25.25%
Dec 31, 2015 9.08%
Sep 30, 2015 12.91%
Jun 30, 2015 -12.88%
Mar 31, 2015 24.69%
Dec 31, 2014 -6.56%
Sep 30, 2014 -11.81%
Jun 30, 2014 -17.77%
Mar 31, 2014 -16.60%
Dec 31, 2013 32.94%
Sep 30, 2013 -10.09%
Jun 30, 2013 -12.13%